N-Acetylcysteine Protection Against Radiation Induced Cellular Damage
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 181 participants.
Also called NCT04154982
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 181 participants
- Registry
-
NCT04154982
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT04154982. Randomized; single masking; primary purpose treatment. Start 2020-09-02 (actual); primary completion 2024-12-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- N-Acetylcysteine Protection Against Radiation Induced Cellular Damage
- Acronym
- CARAPACE
- Condition
- Cardiac Arrhythmia
- Intervention (Drug)
- Acetyl cysteine
- Lead sponsor
- Centro Cardiologico Monzino
- Collaborator
- Ministry of Health, Italy
Record details
- Record id
cardio:ct-nct04154982- Content hash
3ce37e3fc9955cedf806c682e24199ea1a8186d5a01c66e86ea829c17c0dbfb5